Determination of thyroxine enantiomers in pharmaceutical formulation by high-performance liquid chromatography–mass spectrometry with precolumn derivatization

A feasible method for indirect quantification of L-T4 in drugs by iodine determination

In this work, a method combining microwave-induced combustion (MIC) for sample preparation of commercial levothyroxine sodium (L-T₄) drugs (L-T₄: 25-200µg/tablet), and potentiometry with ion selective electrode (ISE) for iodine determination and subsequent indirect quantification of L-T₄ was proposed. The type and concentration of the absorbing solution were evaluated to select the most suitable conditions for this study. Using the MIC method, it was possible to use solutions as diluted as 150mmolL^-1 (NH₄)₂CO₃ (for samples containing 25-200µg of L-T₄/tablet) for I absorption. In these conditions, recoveries for L-T₄ were between 99% and 101%, and relative standard deviations were lower than 10%. The limit of detection for L-T₄ was 11.2µg/tablet, which is almost two times lower than the minimum concentration of L-T₄ in commercially available drugs. Thus, the MIC was suitable for the digestion of several L-T₄ drugs for subsequent I determination by ISE and indirect quantification of L-T₄. Furthermore, the proposed method presents high throughput with low reagent consumption and consequently lower waste generation, making it suitable for routine determination of L-T₄ in drugs. From the obtained results, it was possible to observe that one of the analyzed samples is not in agreement with the limits established by the United States Pharmacopeia, indicating the importance of the drug quality control. The United States Pharmacopeia establishes that each tablet must contain between 90% and 110% of the amount of active substance declared by the manufacturer.

A review of recent advances in mass spectrometric methods for gas-phase chiral analysis of pharmaceutical and biological compounds

Chirality has been of great interest in pharmaceutical and biological sciences. The capabilities of mass spectrometry (MS) for rapid analysis of complex mixtures have encouraged its exploration for gas-phase chiral differentiation. Although particular instances of successful discrimination between enantiomers have been reported over the past three decades, a general method of quantitative chiral analysis by MS has only been demonstrated recently. This review describes the current state of the chiral MS methods without chiral chromatographic separation, which fall into five main categories: (1) the kinetic method, (2) host-guest (H-G) diastereomeric adduct formation, (3) ion/molecule (equilibrium) reactions, (4) collision-induced dissociation (CID) of diastereomeric adducts, and (5) the emerging technique for gas-phase separation using ion mobility spectrometry (IMS). It emphasizes tandem mass spectrometry (MS/MS), which provides several unique analytical advantages for quantitative chiral analysis. These include intrinsically high sensitivity, molecular specificity, and tolerance to impurities as well as the simplicity and speed of the mass spectrometric measurements. Practical prospects and current challenges in quantitative chiral MS techniques for QbD (quality-by-design)-based pharmaceutical applications are also discussed.

Enantiomeric fraction as an indicator of pharmaceutical biotransformation during wastewater treatment and in the environment--a review

Enantioselective analysis of some pharmaceuticals during wastewater treatment has the potential to reveal significant insights regarding the effectiveness of biotransformation processes. Furthermore, enantioselective analysis of chiral pharmaceuticals in the aquatic environment may provide a useful historical record revealing the dominant source of (treated or untreated) wastewater contamination. This review of the recent scientific literature has identified only a handful of studies that have directly investigated these promising applications. However, a range of enantioselective analytical techniques are likely to be adaptable from those which have been developed within the pharmaceutical industry. These include direct enantioseparations of enantiomers on chiral stationary phases as well as indirect separations by achiral stationary phases after chiral derivatization to form pairs of physically distinguishable diastereomers. Further investigations of the patterns of enantiomeric fractionation of pharmaceuticals in wastewater and environmental samples will provide an increasingly solid understanding of the relationship between biotransformation processes and the often overlooked parameter of enantiomeric fraction.

Enatioselective quantitative separation of D- and L-thyroxine by molecularly imprinted micro-solid phase extraction silver fiber coupled with complementary molecularly imprinted polymer-sensor

Thyroxine is a known disease biomarker which demands a highly sensitive and selective technique to measure ultratrace level with enantiodifferentiation of its optical isomers (d- and l-), in real samples. In this work, an approach of hyphenation between molecularly imprinted micro-solid phase extraction and a complementary molecularly imprinted polymer-sensor was adopted for enantioseparation, preconcentration, and analysis of d- and l-thyroxine. In both techniques, the same imprinted polymer, coated on a vinyl functionalized self-assembled monolayer modified silver wire, was used as the respective extraction fiber as well as sensor material. This combination enabled enhanced preconcentration of test analyte substantially so as to achieve the stringent limit [limit of detection: 0.0084 ng mL(-1), RSD=0.81%, S/N=3 (d-thyroxine); 0.0087 ng mL(-1), RSD=0.63%, S/N=3 (l-thyroxine)] of clinical detection of thyroid-related diseases, without any problems of non-specific false-positive contribution and cross-reactivity.